Suppr超能文献

头孢哌酮治疗外科患者胆囊、胆管及肝脏感染

[Cefoperazone in the treatment of infections of the gallbladder, biliary ducts and liver in surgical patients].

作者信息

Vyhnánek F, Lochman O, Pelák Z

机构信息

Chirurgická klinika 3. LF UK, Praha.

出版信息

Rozhl Chir. 1996 Nov;75(11):544-8.

PMID:9072836
Abstract

In 20 patients treated on account of advanced cholecystitis, inflammations of the biliary pathways and liver a cephalosporin of the third generation, cefoperazone, was administered within the framework of antimicrobial treatment after surgery or after endoscopic intervention. In the laboratory investigation of the study in isolated bacteria minimal inhibitory concentrations and serum, biliary and tissue levels of cefoperazone were assessed. The minimal inhibitory concentrations in the assessed bacteria were several times lower than the levels assessed in serum, bile and the wall of the gallbladder. The infection was eradicated in 20 patients. Seventeen patients were cured (85%).

摘要

在20例因晚期胆囊炎、胆道和肝脏炎症接受治疗的患者中,第三代头孢菌素头孢哌酮在手术或内镜干预后的抗菌治疗框架内给药。在该研究的实验室调查中,评估了头孢哌酮在分离细菌中的最低抑菌浓度以及血清、胆汁和组织中的水平。评估细菌中的最低抑菌浓度比血清、胆汁和胆囊壁中的评估水平低几倍。20例患者的感染均被根除。17例患者治愈(85%)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验